title: Disseminated Hailey-Hailey disease treated with topical tacrolimus and oral erythromycin: Case report and review of the literature.
abstract: Hailey-Hailey disease is a rare autosomal dominant skin disorder that typically affects the intertriginous areas. The responsible defect has been identified in the gene named ATP2C1 on chromosome 3q21-24. We present a 50-year-old man with a 16-year history of blistering eruptions and positive familial history where this disease had appeared through four generations. The diagnosis was confirmed by histopathologic studies and negative immunofluorescence findings. A combination of topical tacrolimus therapy and oral erythromycin seemed to play a considerable part in this case, in which all of the lesions healed within 2 weeks.
authors.affiliation: Zagreb-Centar Health Center, Runjaninova 4, HR-10000 Zagreb, Croatia. sanja.persic@email.t-com.hr
authors.forename: Sanja
authors.initials: S
authors.lastname: Persić-Vojinović
authors.forename: Visnja
authors.initials: V
authors.lastname: Milavec-Puretić
authors.forename: Ivan
authors.initials: I
authors.lastname: Dobrić
authors.forename: Jaka
authors.initials: J
authors.lastname: Rados
authors.forename: Sanja
authors.initials: S
authors.lastname: Spoljar
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016506:Pemphigus, Benign Familial / Q000188:drug therapy*; D011500:Protein Synthesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D011500:Protein Synthesis Inhibitors; D004917:Erythromycin; D016559:Tacrolimus